Royal Papworth Hospital is a specialist heart and lung hospital, located on the Cambridge Biomedical Campus in Cambridgeshire, England. The Hospital is run by Royal Papworth Hospital NHS Foundation Trust.

There are 300 beds in Papworth Hospital NHS Foundation Trust.

During the past decade, Papworth Hospital NHS Foundation Trust conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 2 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Papworth Hospital NHS Foundation Trust" #1 sponsor was "Papworth Hospital NHS Foundation Trust" with 5 trials, followed by "Boston Scientific Corporation" with 3 trials sponsored, "Alung Technologies" with 1 trials sponsored, "Edwards Lifesciences" with 1 trials sponsored and "Imperial College London" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Papworth Hospital NHS Foundation Trust" #1 collaborator was "AstraZeneca" with 1 trials as a collaborator, "British Heart Foundation" with 1 trials as a collaborator, "Cambridge University Hospitals NHS Foundation Trust" with 1 trials as a collaborator, "Medtronic" with 1 trials as a collaborator and "Medtronic International Trading Sarl" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 6 trials.

According to Clinical.Site data, the most researched conditions in "Papworth Hospital NHS Foundation Trust" are "Heart Failure" (4 trials), "Ventricular Tachycardia" (2 trials), "Acute Respiratory Distress Syndrome" (1 trials), "Aortic Valve Disorder" (1 trials) and "Aortic Valve Insufficiency" (1 trials). Many other conditions were trialed in "Papworth Hospital NHS Foundation Trust" in a lesser frequency.

Most popular intervention types in "Papworth Hospital NHS Foundation Trust" are "Device" (6 trials), "Drug" (3 trials), "Other" (2 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Cryoballoon PVI" (1 trials), "Glucagon-Like Peptide 1" (1 trials), "Hattler Respiratory Assist Catheter" (1 trials), "ICD" (1 trials) and "Implantation of CEP Magna Ease Model 3300TFX" (1 trials). Other intervention names were less common.

The vast majority of trials in "Papworth Hospital NHS Foundation Trust" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Papworth Hospital NHS Foundation Trust". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Papworth Hospital NHS Foundation Trust, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Papworth Hospital NHS Foundation Trust, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".